In vitro bioassay for transforming growth factor-β using XTT method

Archives of Pharmacal Research

Volumn 25, Issue 6, 2002, Pages 903-909

  Kim, Mi Sung ^a   Ahn, Seong Min ^a   Moon, Aree ^a  

^a Duksung Women's University   (South Korea)

Author keywords

H ras MCF10A; MTT; Mv 1 Lu; TGF ; XTT

Indexed keywords

COLORING AGENT; GROWTH INHIBITOR; TETRAZOLIUM; THIAZOLE DERIVATIVE; THIAZOLYL BLUE; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; CELL LINE; CELL SURVIVAL; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECT; EPITHELIUM CELL; HUMAN; MINK; ONCOGENE RAS; PHYSIOLOGY; SPECTROPHOTOMETRY; VALIDATION STUDY;

ANIMALS; CELL LINE; CELL SURVIVAL; COLORING AGENTS; EPITHELIAL CELLS; GENES, RAS; GROWTH INHIBITORS; HUMANS; MINK; SPECTROPHOTOMETRY; TETRAZOLIUM SALTS; THIAZOLES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0037666121     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02977012     Document Type: Article

References (28)

1. Amatayakul-Chantler, S., Qian, S.W., Gakenheimer, K., Bottinger, E.P., Roberts, A.B., Sporn, M.B. [Ser77]transforming growth factor-beta 1. Selective biological activity and receptor binding in mink lung epithelial cells. J. Biol. Chem., 269, 27687-91 (1994).
2. Barnard, J. A., Lyons, R. M. and Moses, H. L. The cell biology of transforming growth factor . Biochim. Biopsys. Acta, 1032, 79-87 (1990).
3. Border, W. A., Okuda, S., Languino, L. R., Sporn, M. B. and Ruoslahti, E. Supression of experimental glomerulonephrins by antiserum against transforming growth factor-β1. Nature, 356, 371-4 (1990).
4. Chang, Y. C., Yang, S. F., Hsieh, Y. S. Regulation of matrix metalloproteinase-2 production by cytokines and pharmacological agents in human pulp cell cultures. J. Endod., 27, 679-82 (2001).
5. Cuthbert, M. F. and Griffiths, E. Medicines from new biotechnologies. J. Royal. Soc. Med., 81, 126-8 (1988).
6. Eichler, W., Friedrichs, U., Thies, A., Tratz, C., Wiedemann, P. Modulation of matrix metalloproteinase and TIMP-1 expression by cytokines in human RPE cells. Invest. Ophthalmol. Vis. Sci., 43, 2767-73 (2002).
7. Fava, R., Olsen, N., Keski-Oja, J., Moses, H. and Pincus, T. Active and latent forms of transforming growth factor-β activity in synovial effusions. J. Exp. Med., 169, 291-6 (1989).
8. Fujimoto, K., Sheng, H., Shao, J., Beauchamp, R.D. Transforming growth factor-beta1 promotes invasiveness after cellular transformation with activated Ras in intestinal epithelial cells. Exp. Cell Res., 266, 239-49 (2001).
9. Gillio, A. P. and Gabrilove, J. L. Cytokine treatment of inherited bone marrow failure syndromes. Blood, 81, 1669-74 (1993).
10. Graycar, J. L., Millar, D. A., Arrick, B. A., Lyons, R. M., Moses, H. L. and Derynck, R. Human transforming growth factor-β3: recombinant expression, purification and biological activities in comparison with transforming growth factors-β1 and -β2. Mol. Endocrinol., 3, 1977 (1989).
11. Hawser, S. P., Norris, H., Jessup, C. J. and Ghannoum, M. A. Comparison of a 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl]-2H- tetrazolium hydroxide (XTT) colorimetric method with the standardized National Committee for Clinical Laboratory Standards method of testing clinical yeast isolates for susceptibility to antifungal agents. J. Clinical Microbiol., 36, 1450-2 (1998).
12. Julien, P., Berg, T. M. and Lawrence, D. A. Acidic cellular environments: activation of latent TGF and sensitization of cellular responses to TGF and EGF. Int. J. Cancer, 43, 886-91 (1989).
13. Kothapalli, D., Frazier, K. S., Welply, A., Segarini, P. R. and Grotendorst, G. R. Transforming growth factor induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway. Cell Growth Differ., 8, 61-8 (1997)
14. Logu, A. D., Uda, P., Pellerano, M. L., Pusceddu, M. C., Saddi, B. and Schivo, M. L. Comparison of two rapid colorimetric methods for determining resistance of Mycobacterium tuberculosis to Rifampin, Isoniazid, and Streptomycin in liquid medium. Eur. J. Clin. Microbiol. Infect Dis., 20, 33-9 (2001).
15. Meager, A. Assays for transforming growth factor . J. Immunol. Methods, 141, 1-14 (1991).
16. Meshulam, T., Levitz, S.M., Christin, L. and Diamond R. D. A simplifieds new assay for assesment of fungal cell damage with the tetrazolium dye, 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)carbonyl] -2H-tetrazolium-5-carboxanilide (XTT). J. Infec. Diseases, 192, 1153-6 (1995).
17. Mire-Sluis, A. R., Page, L. and Thorpe, R. Quantitative cell line based bioassays for human cytokines. J. Immunol. Methods, 187, 191-9 (1995).
18. Moon, A., Kim, M.-S., Kim, T. G., Kim, S. H., Kim, H. E., Chen, Y. Q. and Kim, H.-R. C. H-ras, but not N- ras, induces an invasive phenotype in human breast epithelial Cells: A role for MMP-2 in the H-ras induced invasive phenotype. Int. J. Cancer, 85, 176-81 (2000).
19. Moses, H. L., Branum, E. L., Proper, J. A. and Robinson, R. A. Transforming growth factor production by chemically transformed cells. Cancer Res., 41, 2842-8 (1981).
20. Oft, M., Heider, K. H., Beug, H. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr. Biol., 8, 1243-52 (1998).
21. Randall, L. A., Wadhwa, M., Thorpe, R. and Mire-Sluis, A. R. A Novel, sensitive bioassay for transforming growth factor . J. Immunol. Methods, 164, 61-7 (1993).
22. Rizzino, A. Soft agar assays for transforming growth factors and mitogenic peptides. In: D. Barnes and D.A. Sirbasku (Eds.), Methods in Enzymology, Vol. 146, Academic Press, Orlando, FL, p341 (1987).
23. Roberts, A. B., Anzano, M. A., Lamb, L. C., Smith, J. M., Frolik, C. A., Marquardt, H., Todaro, G. J. and Sporn, M. B. Isolation from murine sarcoma cells of novel transforming growth factors potentiated by EGF. Nature, 295, 417-9 (1982).
24. Roberts, A. B. and Sporn, M. B. Transforming growth factors. In:M. B. Sporn and A. B. Rolerts(Eds), Peptide growth factors and theis receptors, Vol. 95, Habdbook of Experimental Pharmacology. Springer-Verlag, New York, p. 419 (1990).
25. Scudiero, D. A., Shoemaker, R. H., Paull, K. D., Monks, A., Tierney, S., Nofziger, T. H., Currens, M. J., Seniff, D. and Boyd, M. R. Evaluation of soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Res., 48, 4827-33 (1988).
26. Soule, H., Maloney, T. M., Wolman, S. R., Peterspm, W. D., Brenz, R., Mcgrath, C. M., Russo, J., Pauley, R. J., Jones, R. F. and Brooks, S. C. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res., 50, 6075-86 (1990).
27. Wahl, S. M. Transforming growth factor (TGF-β) in inflammation: a cause and a cure. J. Clin. Immunol., 12. 61-74 (1992).
28. Wick, W., Platten, M., Weller, M. Glioma cell invasion: regulation of metalloproteinase activity by TGF-beta. J. Neurooncol., 53, 177-85 (2001).